Newtown Square, PA
ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products.
arrivent.comThese are collections ArriVent Biopharma is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$75,000,000
IPO
Unknown
Series B
$155,000,000
Series A
$69,000,000
Series A
$81,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ArriVent Biopharma.